至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Crossprotection induced by virus-like particles containing influenza dual-hemagglutinin and M2 ectodomain

Nanomedicine (Lond). 2024-02; 
Jie Mao, Gi-Deok Eom, Keon-Woong Yoon, Min-Ju Kim, Ki-Back Chu, Hae-Ji Kang, Fu-Shi Quan
Products/Services Used Details Operation
Gene Synthesis … of A/Canifornia/04/2009 (H1N1) were synthesized from GenScript (NJ, USA). Each of the genes in pFastBac was transformed into DH10Bac competent cells and the resulting bacmid … Get A Quote

摘要

To develop an effective universal vaccine against antigenically different influenza viruses. We generated influenza virus-like particles (VLPs) expressing the H1 and H3 antigens with or without M2e5x. VLP-induced immune responses and crossprotection against H1N1, H3N2 or H5N1 viruses were assessed to evaluate their protective efficacy. H1H3M2e5x immunization elicited higher crossreactive IgG antibodies than H1H3 VLPs. Upon challenge, both VLPs enhanced lung IgG, IgA and germinal center B-cell responses compared with control. While these VLPs conferred protection, H1H3M2e5x showed greater lung viral load reduction than H1H3 VLPs with minimal body weight loss. Utilizing VLPs containing dual-hemagglutinin, alon... More

关键词

M2e5x, hemagglutinin, influenza virus, universal vaccine, virus-like particles